Centro de Estudos de Doenças Crónicas (CEDOC)

Medicine & Life Sciences

1. Allergic Rhinitis 17%
2. alpha-Synuclein 27%
3. Alzheimer Disease 17%
4. Anaphylaxis 13%
5. Ankylosing Spondylitis 23%
6. Antibodies 15%
7. Antirheumatic Agents 13%
8. Asthma 32%
9. Autophagy 12%
10. Biological Therapy 13%
11. Biomarkers 28%
12. Blood Vessels 14%
13. C-Reactive Protein 20%
14. Carbon Monoxide 22%
15. Caregivers 27%
16. Carotid Body 37%
17. Carotid Sinus 14%
18. Cell Death 14%
19. Child 18%
20. Chronic Disease 12%
21. Cilia 19%
22. Cognitive Dysfunction 16%
23. Cohort Studies 19%
24. Comorbidity 14%
25. Consensus 13%
26. Coronary Artery Disease 13%
27. Coronavirus 13%
28. Cross-Sectional Studies 18%
29. Delivery of Health Care 15%
30. Dementia 37%
31. Depression 23%
32. Diagnostic and Statistical Manual of Mental Disorders 15%
33. Diet 16%
34. Economics 19%
35. Elderly 14%
36. Extracellular Vesicles 16%
37. Fibromyalgia 13%
38. Genes 25%
39. Global Health 62%
40. Glucose 20%
41. Guidelines 15%
42. Health 26%
43. Health Surveys 63%
44. Homeostasis 15%
45. Hypersensitivity 15%
46. Hypertension 13%
47. Hypoxia 21%
48. In Vitro Techniques 17%
49. Income 18%
50. Infections 19%
51. Inflammation 19%
52. Insulin 18%
53. Insulin Resistance 23%
54. Intensive Care Units 17%
55. Interviews 15%
56. Juvenile Arthritis 13%
57. Kidney 15%
58. Liver 19%
59. Lysosomes 14%
60. Membranes 15%
61. Mental Disorders 35%
62. Mental Health 64%
63. Meta-Analysis 19%
64. Mortality 17%
65. Musculoskeletal Diseases 18%
66. Mutation 23%
67. Neoplasms 34%
68. Neurodegenerative Diseases 12%
69. Nevirapine 15%
70. Odds Ratio 13%
71. Osteoarthritis 26%
72. Osteoporosis 16%
73. Pandemics 14%
74. Parkinson Disease 40%
75. Pharmaceutical Preparations 25%
76. Phenols 13%
77. Phenotype 24%
78. Physicians 12%
79. Population 34%
80. Portugal 100%
81. Proteins 33%
82. Quality of Life 25%
83. Registries 18%
84. REM Sleep Behavior Disorder 14%
85. Retinal Pigment Epithelium 16%
86. Rheumatic Diseases 38%
87. Rheumatoid Arthritis 21%
88. Rheumatologists 16%
89. Rheumatology 16%
90. SARS Virus 16%
91. Stroke 14%
92. Synucleinopathies 19%
93. Synucleins 19%
94. Systematic Reviews 35%
95. T-Lymphocytes 13%
96. Therapeutics 42%
97. Tumor Necrosis Factor Inhibitors 13%
98. Type 2 Diabetes Mellitus 15%
99. Ventilator-Associated Pneumonia 13%
100. Zebrafish 36%